Clinical Trials Directory

Trials / Enrolling By Invitation

Enrolling By InvitationNCT06836531

POCT Detection for Blood Concentration of Tirofiban in Acute Myocardial Infarction Based on Azo-POP Probe.

POCT Detection for Blood Concentration of Tirofiban in Acute Myocardial Infarction Based on Azo-POP Probe, and Use Metabolomics Analysis Combined with Machine Learning Algorithms for Screening Biomarkers of Myocardial Infarction.

Status
Enrolling By Invitation
Phase
Study type
Observational
Enrollment
100 (estimated)
Sponsor
First Affiliated Hospital of Ningbo University · Network
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Accepted

Summary

The goal of this observational study is to monitor blood drug concentration during the use of tirofiban, predict the occurrence of intraoperative and postoperative complications related to interventional therapy, and evaluate the efficacy of multiple antiplatelet drugs.The main question it aims to answer is: 1. If the POCT detection technology for blood concentration of tirofiban based on portable mass spectrometer can be used for on-site sampling, clinical testing, and immediate analysis next to patients undergoing coronary intervention therapy. 2. LC-MS/MS untargeted metabolomics analysis techniques combined with machine learning algorithms will be used to screen biomarkers for myocardial infarction.

Conditions

Timeline

Start date
2025-03-30
Primary completion
2025-07-31
Completion
2025-07-31
First posted
2025-02-20
Last updated
2025-03-25

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06836531. Inclusion in this directory is not an endorsement.